Cubist Systematic Strategies, LLC Prothena Corp Public LTD CO Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$24.75 - $40.66 $3.1 Million - $5.1 Million	125,442 Added 1269.78%	135,321 $3.35 Million
Q4 2023 Feb 14, 2024	BUY	$32.31 - $52.32 $319,190 - $516,869	9,879 New	9,879 $359,000
Q2 2023 Aug 14, 2023	SELL	$48.26 - $78.59 $1.82 Million - $2.97 Million	-37,741 Reduced 92.28%	3,159 $215,000
Q1 2023 May 15, 2023	BUY	$46.97 - $58.27 $8,501 - $10,546	181 Added 0.44%	40,900 $1.98 Million
Q4 2022 Feb 14, 2023	BUY	$52.05 - $65.0 $1.2 Million - $1.49 Million	22,999 Added 129.79%	40,719 $2.45 Million
Q3 2022 Nov 14, 2022	BUY	$25.16 - $60.63 $129,322 - $311,638	5,140 Added 40.86%	17,720 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$22.73 - $39.98 $97,875 - $172,153	4,306 Added 52.04%	12,580 $342,000
Q1 2022 May 16, 2022	SELL	$30.27 - $49.22 $1.04 Million - $1.69 Million	-34,331 Reduced 80.58%	8,274 $303,000
Q4 2021 Feb 14, 2022	BUY	$42.11 - $73.26 $14,443 - $25,128	343 Added 0.81%	42,605 $2.11 Million
Q3 2021 Nov 15, 2021	BUY	$48.2 - $78.89 $710,082 - $1.16 Million	14,732 Added 53.51%	42,262 $3.01 Million
Q2 2021 Aug 16, 2021	BUY	$21.63 - $57.65 $222,983 - $594,313	10,309 Added 59.86%	27,530 $1.42 Million
Q1 2021 May 17, 2021	BUY	$11.0 - $28.24 $189,431 - $486,321	17,221 New	17,221 $433,000
Q4 2020 Feb 16, 2021	SELL	$10.12 - $13.94 $238,012 - $327,854	-23,519 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.93 - $13.47 $115,515 - $156,696	11,633 Added 97.87%	23,519 $235,000
Q2 2020 Aug 14, 2020	BUY	$9.56 - $12.51 $46,528 - $60,886	4,867 Added 69.34%	11,886 $124,000
Q1 2020 May 15, 2020	SELL	$7.54 - $15.77 $58,487 - $122,327	-7,757 Reduced 52.5%	7,019 $75,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $17.01 $1,286 - $2,925	172 Added 1.18%	14,776 $234,000
Q3 2019 Nov 14, 2019	SELL	$6.89 - $10.45 $214,616 - $325,507	-31,149 Reduced 68.08%	14,604 $114,000
Q2 2019 Aug 14, 2019	BUY	$8.85 - $12.49 $280,235 - $395,495	31,665 Added 224.77%	45,753 $484,000
Q1 2019 May 15, 2019	BUY	$10.32 - $14.49 $29,824 - $41,876	2,890 Added 25.81%	14,088 $171,000
Q4 2018 Feb 14, 2019	BUY	$8.73 - $13.74 $97,758 - $153,860	11,198 New	11,198 $115,000

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

Eco R1 Capital, LLC San Francisco, CA

11.6M
Shares

$176 Million
8.41% of portfolio
Wellington Management Group LLP Boston, MA

4.18M
Shares

$63.6 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.86M
Shares

$58.7 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.82M
Shares

$58.2 Million
0.01% of portfolio
Palo Alto Investors LP Palo Alto, CA

1.74M
Shares

$26.5 Million
4.0% of portfolio

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account